Publications by the researcher in collaboration with Iván Alejandro Ferraz Amaro (21)

2021

  1. Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1834-1844

  2. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis

    Arthritis Research and Therapy, Vol. 23, Núm. 1

  3. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596

2020

  1. Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 38, pp. S18-S24

  2. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

  3. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients

    Clinical Rheumatology, Vol. 39, Núm. 6, pp. 1871-1880

2019

  1. Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients

    Hormone and Metabolic Research, Vol. 51, Núm. 3, pp. 200-209

2017

  1. HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2015

  1. Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 516-523

  2. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 241-249

2014

  1. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 1, pp. 1-8

  2. Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function

    Journal of Rheumatology, Vol. 41, Núm. 4, pp. 658-665

  3. Influence of disease activity on the physical activity of rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 53, Núm. 4, pp. 722-731

2013

  1. Cholesteryl ester transfer protein in patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 40, Núm. 7, pp. 1040-1047

2012

  1. Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients

    Arthritis Research and Therapy, Vol. 15, Núm. 1

2011

  1. Resistencia insulínica y artritis reumatoide

    Reumatologia Clinica

  2. Mujer con artralgias y aumento de tamaño de miembros superiores

    Reumatologia Clinica, Vol. 7, Núm. 3, pp. 210-211

2009

  1. Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice

    Reumatologia Clinica, Vol. 5, Núm. 6, pp. 252-258

2004

  1. Dual positivity for cytoplasmic and perinuclear antineutrophil antibodies in a patient with Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 2, pp. 233-234

2003

  1. Alergia a los glucocorticoides: ¿Una paradoja?

    Medicina Clinica, Vol. 120, Núm. 4, pp. 141-145